UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 1, 2018

 


 

SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware
Delaware

 

001-34465
001-31441

 

20-1764048
23-2872718

(State or other jurisdiction of
Incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer
Identification No.)

 


 

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of principal executive offices)  (Zip Code)

 

(717) 972-1100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether either registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if either registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 



 

Item 5.07                   Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders (the “Annual Meeting”) of Select Medical Holdings Corporation (the “Company”) was held on May 1, 2018.  At the Annual Meeting, the Company’s stockholders approved three proposals.  The proposals below are described in the Company’s definitive proxy statement dated March 7, 2018.  The results are as follows:

 

Proposal 1: The Election of Three Class III Directors to the Board of Directors

 

Name

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

James S. Ely III

 

108,563,219

 

16,518,703

 

7,745

 

4,282,973

 

Rocco A. Ortenzio

 

114,372,840

 

10,709,268

 

7,559

 

4,282,973

 

Thomas A. Scully

 

114,204,876

 

10,877,528

 

7,263

 

4,282,973

 

 

Proposal 2:  Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

122,714,386

 

2,301,208

 

74,073

 

4,282,973

 

 

Proposal 3:  Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2018

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

128,304,624

 

1,047,720

 

20,296

 

0

 

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

 

SELECT MEDICAL HOLDINGS CORPORATION

 

SELECT MEDICAL CORPORATION

 

 

 

 

Date: May 2, 2018

By:

/s/ Michael E. Tarvin

 

 

Michael E. Tarvin

 

 

Executive Vice President, General Counsel and Secretary

 

3